Santamato Andrea, Micello Maria Francesca, Panza Francesco, Fortunato Francesca, Picelli Alessandro, Smania Nicola, Logroscino Giancarlo, Fiore Pietro, Ranieri Maurizio
Department of Physical Medicine and Rehabilitation, "OORR Hospital", University of Foggia, Foggia, Italy.
Neurodegenerative Disease Unit, University of Bari Aldo Moro, Bari, Italy Department of Clinical Research in Neurology, University of Bari Aldo Moro, "Pia Fondazione Cardinale G. Panico", Tricase, Italy
Clin Rehabil. 2015 Jan;29(1):50-8. doi: 10.1177/0269215514537915. Epub 2014 Jun 10.
To compare the effectiveness of two procedures increasing the botulinum toxin type A effect for wrist and finger flexor spasticity after stroke.
A single-blind randomized trial.
Seventy patients with upper limb post-stroke spasticity.
Adults with wrist and finger flexor muscles spasticity after stroke were submitted to botulinum toxin type A therapy. After the treatment, the subjects injected were randomly divided into two groups and submitted to adhesive taping (Group A) or daily muscle manual stretching, passive articular mobilization of wrist and fingers, and palmar splint (Group B) for 10 days. We measured spasticity with Modified Ashworth Scale, related disability with Disability Assessment Scale, and fingers position at rest. The measurements were done at baseline, after two weeks, and after one month from the treatment session.
After two weeks, subjects in Group A reported a significantly greater decrease in spasticity scores (Modified Ashworth Scale fingers: mean (standard deviation) 1.3±0.6 vs. 2.1±0.6; Modified Ashworth Scale wrist: 1.7 ±0.6 vs. 2.3 ±0.8), and after one month in spasticity and disability scores (Modified Ashworth Scale fingers: mean (standard deviation) 1.9 ±0.7 vs. 2.5 ±0.6; Modified Ashworth Scale wrist: 2.0 ±0.7 vs. 2.6 ±0.6; Disability Assessment Scale: 1.6 ±0.7 vs. 2.1 ±0.7) compared with Group B subjects. Subjects in Group A reported also a significantly improved fingers position at rest compared with Group B subjects after two weeks (2.8 ±0.9 vs. 2.1 ±0.7) and one month (2.3 ±0.7 vs. 1.5 ±0.6).
Adhesive taping of wrist and finger flexor muscles appeared to enhance the effect of botulinum toxin type A therapy more than daily manual muscle stretching combined with passive articular mobilization and palmar splint.
比较两种增强A型肉毒杆菌毒素对中风后手腕和手指屈肌痉挛疗效的方法的有效性。
单盲随机试验。
70例上肢中风后痉挛患者。
患有中风后手腕和手指屈肌痉挛的成年人接受A型肉毒杆菌毒素治疗。治疗后,将注射的受试者随机分为两组,分别接受粘贴胶带治疗(A组)或每日肌肉手动拉伸、手腕和手指的被动关节活动及掌侧夹板治疗(B组),为期10天。我们用改良Ashworth量表测量痉挛程度,用残疾评估量表测量相关残疾情况,并测量手指静止时的位置。测量在基线、治疗后两周和治疗后一个月进行。
两周后,A组受试者的痉挛评分显著降低(改良Ashworth量表手指:均值(标准差)1.3±0.6 vs. 2.1±0.6;改良Ashworth量表手腕:1.7±0.6 vs. 2.3±0.8),一个月后,痉挛和残疾评分也显著降低(改良Ashworth量表手指:均值(标准差)1.9±0.7 vs. 2.5±0.6;改良Ashworth量表手腕:2.0±0.7 vs. 2.6±0.6;残疾评估量表:1.6±0.7 vs. 2.1±0.7),与B组受试者相比。与B组受试者相比,A组受试者在两周(2.8±0.9 vs. 2.1±0.7)和一个月(2.3±0.7 vs. 1.5±0.6)后手指静止时的位置也显著改善。
手腕和手指屈肌的粘贴胶带治疗似乎比每日手动肌肉拉伸联合被动关节活动及掌侧夹板治疗更能增强A型肉毒杆菌毒素治疗的效果。